The 21st century is a time of great innovation. Some of the most advanced products and services have come from this era. On the other hand, the 21st century is still dealing with the many deadly illnesses that plagues us as a people. Cancer is one of the main players, and it has been around for decades and decades. This deadly disease can manifest out of the blue in some of the human body’s most vital organs. Fortunately, the fight against cancer has never looked brighter than it is today. Some of the most advanced medicines are stopping it in its tracks and are saving lives. This is where Dr. Clay Siegal comes into the frame as he has played a critical role in the grand scheme of things.
Dr. Siegall is a well-respected individual in the cancer research sector of business. The guy has literally dedicated his life to fighting cancer. With a Ph.D in Genetics from George Washington University and a B.S. in Zoology from the University of Maryland, Siegall has more than enough capability to get the job done right. He’s worked with many of today’s most high profile companies such as GlaxoSmithKline, Bristol Myers Squibb, the National Cancer Society and the National Institute of Health.
Siegall is a constant blogger in his own right, and he keeps the general public informed with what’s happening in cancer research. Some of his latest blogs spoke on a number of topics such as the Paris Climate Agreement, President Trump’s decision for the Paris Accord and Sustainability and news from the NPR.
One of the leading organizations for cancer research is Seattle Genetics and Siegall just so happens to be its president and founder. Seattle Genetics has been around since the late 1990s, and it has produced some of the best cancer fighting medicines of all-time. Antibody Based Therapies are the treatments and Seattle Genetics is in control of it all. The future is in good hands thanks to Clay Siegall, and his revolutionary company.